Specifically, we demonstrated that 1) GSK3β-mediated phosphorylation of ETS1 regulates its protein stability and transcriptional activity and 2) the expression levels of phospho-ETS1 are associated with ovarian cancer stage and can be used as a biomarker to predict overall survival in this malignancy. This evidence concerns the gene GSK3B and ovarian carcinoma.